Simulation of Boron Dose and Irradiation Time in Lung Cancer Treatment with Boron Neutron Capture Therapy (BNCT) Using MCNP-6

Nita Handayani, Kevin Kautsar Soelistiyono, Fajar Arianto

Abstract

Boron Neutron Capture Therapy (BNCT) is a cancer radiation treatment. This approach employs a boron carrier agent in the form of a chemical that is injected into the body and then travels to the cancer cells. In a lung cancer case study, BNCT treatment simulation was carried out using Monte Carlo N Particle (MCNP) software version 6.2. The goal of this study was to determine the most effective boron concentration and irradiation duration in lung cancer therapy utilizing the BNCT method. The geometry based on a phantom model created by Oak Ridge National Laboratory (ORNL). The simulated cancer geometry, which is placed in the right lung's middle lobe. The skin, ribs, and right lung are among the organs at risk. The skin, ribs, and right lung are among the organs at risk. The neutron source for the simulation is the collimator output from the Kartini Nuclear Reactor's thermal column. In this simulation, the variations in boron concentrations were 40 g/g, 45 g/g, 50 g/g, 55 g/g, and 60 g/g of cancer tissue at 5 g/g intervals. The researchers discovered a link between boron injection concentration and irradiation time, with higher boron injection concentrations resulting in shorter irradiation times. The volume of boron injected determines the effective dose absorbed by healthy tissue surrounding cancer cells. The effective boron concentration for lung cancer therapy is 60 g/g, with deterministic cell killing in the rib marrow and right lung. When utilizing a boron concentration of 60 g/g, the irradiation time is 20.4 minutes. Boron concentrations of 60 g/g are projected to create an effective irradiation time for BNCT-based lung cancer therapy based on the ALARA principle due to their shorter duration when compared to other concentration variations.

Keywords

Boron dose; BNCT; lung cancer; Monte Carlo

Full Text:

PDF

References

1 GLOBOCAN. 2020. Estimated Number of Cancer Incidence, Mortality, and Prevalence Worldwide in 2020. International Agency of Research for Cancer.

2 Kementerian Kesehatan Republik Indonesia. 2017. Pedoman Nasional Pelayanan Kedokteran (PNPK) Untuk Kanker Paru. Online: https://www.kemkes.go.id/id/media/subfolder/pedoman/pedoman-nasional-pelayanan-kedokteran-pnpk.

3 Sauerwein, W., Wittig, A., Moss, R., & Nakagawa Y. 2012. Neutron Capture Therapy - Principles and Applications. Springer-Verlag Berlin Heidelberg. Berlin Heidelberg Jerman. JRC77319.

4 Ardana, I.M., Noerwasana, A.D., & Sardjono, Y. 2018. Kajian Teknologi Boron Neutron Capture Therapy (BNCT) dan Aspek Regulasinya. Prosiding Seminar Keselamatan Nuklir. 95-101.

5 Sauerwein, W.A.G., Pierre M. B., & Wittig, A. 2012. Drugs for BNCT: BSH and BPA. Jurnal Neutron Capture Therapy: 117-140.

6 Ting, G., Chang, C. H., Wang, H. E., & Lee, T. W. 2010. Nanotargeted radionuclides for cancer nuclear imaging and internal radiotherapy. Journal of biomedicine & biotechnology, 2010, 953537.

7 Hidayatullah, R., 2017. Dampak tingkat radiasi pada tubuh manusia. Jurnal Mutiara Elektromedik, 1(1).

8 Harish, A.F., Dwijohartoko, W., & Sardjono, Y. 2018. Dose analysis of boron neutron capture therapy (BNCT) treatment for lung cancer based on particle and heavy ion transport code system (PHITS). ASEAN Journal On Science & Technology for Development, 35(3), 187-194.

9 Fauziah, N., Widiharto A., & Sardjono, Y. 2013. A Conceptual design of neutron collimator in the thermal column of Kartini research reactor for in vitro and in vivo test of boron neutron capture therapy. Jurnal Teknologi Reaktor Nuklir. 15(2), 112-119.

10 Tesalonika, A., Widiharto, A., Sardjono, Y., & Triatmoko, I. M. 2016. Dosimetry of in vitro and in vivo trials in thermal column Kartini reactor for boron neutron capture therapy (BNCT) facility by using MCNPX Simulator Code. Indonesian Journal of Physics and Nuclear Applications, 1(2), 63-72.

11 IAEA. 2001. Current status of neutron capture therapy. IAEA-TECDOC-1223. Vienna, Austria.

12 Suzuki, M., Suzuki, O., Sakurai, Y., Tanaka, H., Kondo, N., Kinashi, Y. Masunaga, Maruhashi, A. & Ono, K. 2012. Reirradiation for locally recurrent lung cancer in the chest wall with boron neutron capture therapy (BNCT). International Cancer Conference Journal, 1, 235-238.

13 Yeung, A.W.K. 2019. The “As Low As Reasonably Achievable” (ALARA) principle: a brief historical overview and a bibliometric analysis of the most cited publications. Radioprotection, 54(2), 103-109.


14 International Atomic Energy Agency. 1998. Health Surveillance of Persons Occupationally Exposed to Ionizing Radiation: Guidance for Occupational Physicians, Safety Reports Series 5, Vienna, Austria.

Refbacks

  • There are currently no refbacks.